Cite
Commentary on the EMA reflection paper on the pharmaceutical development of medicines for use in the older population
MLA
Riet-Nales, D. A.van, et al. “Commentary on the EMA Reflection Paper on the Pharmaceutical Development of Medicines for Use in the Older Population.” British Journal of Clinical Pharmacology, 2022. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsoai&AN=edsoai.on1313515399&authtype=sso&custid=ns315887.
APA
Riet-Nales, D. A. van, Bemt, B. J. . van den, Bodegom, D. van, Cerreta, F., Dooley, B., Eggenschwyler, D., Hirschlérova, B., Jansen, P. A. F., Karapinar-Çarkit, F., Moran, A., Span, J., Stegemann, S., & Sundberg, K. (2022). Commentary on the EMA reflection paper on the pharmaceutical development of medicines for use in the older population. British Journal of Clinical Pharmacology.
Chicago
Riet-Nales, D.A. van, B.J.F van den Bemt, D. van Bodegom, F. Cerreta, Brian Dooley, D. Eggenschwyler, B. Hirschlérova, et al. 2022. “Commentary on the EMA Reflection Paper on the Pharmaceutical Development of Medicines for Use in the Older Population.” British Journal of Clinical Pharmacology. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsoai&AN=edsoai.on1313515399&authtype=sso&custid=ns315887.